Other Titles

Maternal-Child Health Nurse Leadership Academy (MCHNLA) Posters

Abstract

Develop a validated screening instrument to identify women at risk or exhibiting symptoms of PMAD during the immediate postpartum period to improve behavioral health referral process and access to community support. Providing early recognition and treatment of this medical disorder are crucial to improve health outcomes for women and children.

Description

45th Biennial Convention 2019 Theme: Connect. Collaborate. Catalyze.

Author Details

Mary Lynn C. Brassil, MS, BSN, RN, CES, C-EFM - Department of MCH Nursing, NYU Winthrop Hospital, Mineola, NY, USA; Julia Snethen, PhD, RN, FAAN - College of Nursing, University of Wisconsin-Milwaukee, Milwaukee, WI, USA; Alice Marie Nash, PhD, MA, RNC-NIC - NYU Winthrop Hospital, Mineola, NY, USA

Sigma Membership

Epsilon Lambda

Lead Author Affiliation

New York University Winthrop Hospital, Mineola, New York, USA

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Instrument Design (CVI), Instrument Design, Maternal Child Health, Perinatal Mood Disorders (PMAD), Paternal Mood Disorders, Screening Tool, CVI, PMAD

Conference Name

45th Biennial Convention

Conference Host

Sigma Theta Tau International

Conference Location

Washington, DC, USA

Conference Year

2019

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (210 kB)

Share

COinS
 

Risk assessment screening instrument for perinatal mood and anxiety disorders (PMAD) during immediate postpartum period

Washington, DC, USA

Develop a validated screening instrument to identify women at risk or exhibiting symptoms of PMAD during the immediate postpartum period to improve behavioral health referral process and access to community support. Providing early recognition and treatment of this medical disorder are crucial to improve health outcomes for women and children.